Condition
Diabetic Foot Ulcer (DFU)
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 56 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
56 shownThe Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.NCT07768228 · 2026-09-01
RECRUITINGHPTC Versus AFSM in Diabetic Foot UlcersNCT07781917 · 2026-08-28
RECRUITINGA Study Comparing an Investigational Wound Gel With Standard Treatment for Mild to Moderate Diabetic Foot UlcersNCT07783087 · 2026-08-10
RECRUITINGEffect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal UlcersNCT07747896 · 2026-08-01
RECRUITINGCAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUsNCT07701590 · 2026-06-22
RECRUITINGControlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of CareNCT07096934 · 2026-06-01
RECRUITINGPAW-Hydrogel for Chronic Wound HealingNCT07541196 · 2026-04-20
RECRUITINGPhase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers:NCT07488247 · 2026-04-02
RECRUITINGPhase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation TissueNCT07498218 · 2026-03-11
RECRUITINGA Non-Randomized Open Label Clinical Trial Evaluating DermaBind TLNCT07172893 · 2025-12-10
RECRUITINGCAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW PopulationsNCT07046767 · 2025-10-01
RECRUITINGA Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUsNCT07116174 · 2025-08-15
RECRUITINGEffect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.NCT07209475 · 2025-08-14
RECRUITINGCARE-D-FOOT-Nav PilotNCT07143175 · 2025-08-05
RECRUITINGRandomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound TherapyNCT07086443 · 2025-07-11
RECRUITINGSafety and Preliminary Efficacy of TrophiPatch, an Adipose-Derived Stromal Cell Patch for Chronic Leg UlcersNCT07048054 · 2025-07-01
RECRUITINGRising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot UlcersNCT06681428 · 2024-11-14
RECRUITINGModified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUsNCT06449638 · 2024-07-16
RECRUITINGDiaFootCare to Promote Self-Care of Diabetic Foot Ulcers in OmanNCT07815275 · 2026-09-13
NOT_YET_RECRUITINGEvaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot UlcersNCT07840378 · 2026-09-01
NOT_YET_RECRUITINGThe ProActive Study- Integrating a Proactive and Palliative Care Approach to Diabetic Ulcer CareNCT07781111 · 2026-09-01
NOT_YET_RECRUITINGModified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal DFUsNCT07449975 · 2026-07-01
NOT_YET_RECRUITINGRisk Perception Intervention for High-Risk Diabetic FootNCT07581262 · 2026-05-01
NOT_YET_RECRUITINGEvaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot UlcersNCT07290673 · 2026-04-01
NOT_YET_RECRUITINGAI-Based Diabetic Foot Recurrence CohortNCT07452354 · 2026-03-15
NOT_YET_RECRUITINGEvaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound HealingNCT07375160 · 2026-03-12
ACTIVE_NOT_RECRUITINGVinegar vs Normal Saline Dressing for Diabetic Foot UlcersNCT07373327 · 2026-02-04
NOT_YET_RECRUITINGAI Wound Alert & Home Management for Recurrent DFUNCT07277010 · 2026-01-01
NOT_YET_RECRUITINGAir-Dried Human Amniotic Membrane Terminally Sterilized by Gamma Irradiation for Multidisciplinary Clinical ApplicationNCT07466576 · 2025-11-01
ACTIVE_NOT_RECRUITINGHEAL-4: Real-World Effectiveness of 4 Amniotic Allografts Adjunctive to Standard Care in DFU, VLU, and PUNCT07223515 · 2025-10-24
ACTIVE_NOT_RECRUITINGCHEMfoot: DEBRICHEM® in Chronic Diabetic Foot WoundsNCT07206862 · 2025-10-01
NOT_YET_RECRUITINGReal-World Effectiveness of Amniotic Membrane Allografts Versus Standard Wound Care in DFU, VLU, and PUNCT07223281 · 2025-09-25
ACTIVE_NOT_RECRUITINGImplementation of a Diabetic Foot Prevention Strategy in Primary Care (iMplanta Study)NCT07004179 · 2025-09-01
NOT_YET_RECRUITINGStudy to Assess Remote Imaging System to Monitor Diabetic Foot UlcersNCT07013448 · 2025-09-01
NOT_YET_RECRUITINGMulticentric RCT Comparing High Purity Type I Collagen-Skin Substitute vs dHACM in Treatment of Diabetic Foot UlcersNCT07046403 · 2025-07-05
COMPLETEDEffect of Foot-ankle Exercise Using Elastic BandNCT07229794 · 2025-07-01
ACTIVE_NOT_RECRUITINGFollow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)NCT07023965 · 2025-06-30
ENROLLING_BY_INVITATIONMatrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot UlcersNCT07116876 · 2025-06-26
ACTIVE_NOT_RECRUITINGEvaluation of Cold Plasma in Chronic Wound HealingNCT06964048 · 2025-06-01
NOT_YET_RECRUITINGA Real World Data Collection of Human Amniotic Membrane(s) on Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers and Post Operative WoundsNCT07078968 · 2025-04-23
COMPLETEDThe Effects of Bromelain Supplement in Patients with Diabetic Foot UlcersNCT06786403 · 2025-03-01
NOT_YET_RECRUITINGRemote Temperature and Visual Monitoring To Help Manage Diabetic Foot UlcersNCT06782386 · 2025-02-05
ACTIVE_NOT_RECRUITINGThe Effect of Using Insoles Specially Designed for Diabetic Foot on Postural Balance and Gait ParametersNCT06846476 · 2024-12-24
COMPLETEDLow-level Laser Therapy Versus Offloading Exercises on Foot Ulcer Healing in Patients with Type 2 DiabetesNCT06670417 · 2024-11-30
UNKNOWNPredictive Analysis of Diabetic Foot UlcerNCT06768554 · 2024-10-31
ACTIVE_NOT_RECRUITINGEffectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound ManagementNCT07549737 · 2024-07-17
COMPLETEDHigh Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUsNCT06470087 · 2024-06-03
COMPLETEDAcute-to-chronic Glycemic Ratio (ACGR) is a Marker of DFUs .NCT06725238 · 2024-05-01
COMPLETEDEfficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical TrialNCT06812637 · 2024-04-06
COMPLETEDArtacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.NCT07219004 · 2023-03-03
COMPLETEDComparison of Posterior Slab Cast With Total Contact Cast in the Management of Diabetic Foot UlcersNCT07111741 · 2023-01-04
COMPLETEDExploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)NCT05438251 · 2022-08-04
TERMINATEDMultidisciplinary Approach to Improve Diabetic Foot Care: an Investigation of Clinical and Economic Outcomes.NCT06658691 · 2022-07-17
COMPLETEDA Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot UlcerNCT04277598 · 2020-10-09
COMPLETEDEffect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer PatientsNCT04372355 · 2019-06-19
COMPLETEDAskina Calgitrol Paste Diabetic Foot UlcersNCT01912092 · 2013-04-01
COMPLETEDCommon interventions
Standard of CareOTHER3Standard of Care (SOC)OTHER3High Purity Type-I Collagen-based Skin Substitute and SOCDEVICE26 Minute Walk Test (6MWT)OTHER1Acellular Intact Fish Skin Matrix and SOCDEVICE1Activate™ MatrixOTHER1Acute-to-chronic glycemic ratioOTHER1Air-Dried Human Amniotic Membrane (AD-hAM)BIOLOGICAL1AllograftOTHER1Amnio-Maxx® Dual Layer Amnion PatchBIOLOGICAL1AmnioDefend™ FT MatrixOTHER1amniotic membraneOTHER1an allogenic cell-based product, containing living human bone marrow-derived mesenchymal stem cells (MSCs) and MSCs differentiated into adipocytes on a porous chitosan-gelatin matrixDRUG1APO-2BIOLOGICAL1Askina Calgitrol pasteDEVICE1BromelainDIETARY_SUPPLEMENT1Buerger Allen exerciseOTHER1Chlorin E6 GelCOMBINATION_PRODUCT1CogenexOTHER1Cold Atmospheric Plasma treatmentDEVICE1Comprehensive Assistance and Resources for Effective Diabetic Foot NavigationOTHER1coordinated primary-care-based MDT-modelOTHER1Corplex PDEVICE1DEBRICHEM®DEVICE1Dehydrated Human Amnion / Chorion Membrane and SOCDEVICE1
Leading sponsors
Adichunchanagiri Institute of Medical Sciences, B G Nagara
3
Capsicure, LLC
2
Peking University Third Hospital
2
StimLabs
2
Tides Medical
2
Ain Shams University
1
Aposcience AG
1
Ayu, Inc.
1
BBraun Medical SAS
1
Beijing Northland Biotech. Co., Ltd.
1
Benjamín Gonzalo Rodríguez Méndez
1
BioLab Holdings
1
Bluedrop Medical Limited
1
Cairo University
1
Cellution Biologics
1
Trial status mix
RECRUITING18
NOT_YET_RECRUITING14
COMPLETED13
ACTIVE_NOT_RECRUITING8
ENROLLING_BY_INVITATION1
TERMINATED1
UNKNOWN1
Phase mix
NA30
PHASE17
PHASE26
PHASE44
PHASE32
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.